Bat-Borne Influenza A Viruses: An Awakening.

Animals Chiroptera / virology Humans Influenza A virus / metabolism Viral Tropism Viral Zoonoses Virus Replication

Journal

Cold Spring Harbor perspectives in medicine
ISSN: 2157-1422
Titre abrégé: Cold Spring Harb Perspect Med
Pays: United States
ID NLM: 101571139

Informations de publication

Date de publication:
01 02 2021
Historique:
pubmed: 25 12 2019
medline: 15 12 2021
entrez: 25 12 2019
Statut: epublish

Résumé

Influenza A viruses (IAVs) originating from aquatic waterfowl recurrently cross interspecies barriers, which is greatly facilitated by utilizing cell surface-exposed monosaccharide sialic acids located on vertebrate cells as a universal host cell receptor. These glycan structures are first bound by the viral hemagglutinin (HA) for cell entry and then cleaved by the viral neuraminidase (NA) for particle release. In contrast, viruses of the recently identified bat-borne IAV subtypes H17N10 and H18N11 encode HA and NA homologs unable to interact with sialic acid residues despite a high degree of structural homology with their conventional counterparts. However, the most recent findings show that bat IAV HAs make use of the major histocompatibility complex class II proteins of different vertebrate species to gain entry into host cells, potentially permitting a broader host tropism. This review recapitulates current progress in the field of bat IAV research including the first assessment of the spillover potential of these bat viruses into other mammals.

Identifiants

DOI: 10.1101/cshperspect.a038612 PMID: 31871229 PMC: PMC7849349
pubmed: 31871229
pii: cshperspect.a038612
doi: 10.1101/cshperspect.a038612
pmc: PMC7849349
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 Cold Spring Harbor Laboratory Press; all rights reserved.

Références

Influenza Other Respir Viruses. 2016 Mar;10(2):122-6
pubmed: 26526406
PLoS Pathog. 2017 Aug 24;13(8):e1006450
pubmed: 28837690
J Gen Virol. 2017 Oct;98(10):2393-2400
pubmed: 28906230
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18897-902
pubmed: 23012237
Nat Microbiol. 2019 Dec;4(12):2035-2038
pubmed: 31358984
J Gen Virol. 1993 Jul;74 ( Pt 7):1327-33
pubmed: 8336121
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1458-63
pubmed: 23297216
J Virol. 2003 Oct;77(19):10575-83
pubmed: 12970442
J Virol. 1972 Oct;10(4):795-800
pubmed: 4117350
PLoS Pathog. 2013 Mar;9(3):e1003279
pubmed: 23555271
J Gen Virol. 1971 Dec;13(3):481-3
pubmed: 4110613
J Virol. 2013 Dec;87(24):13556-68
pubmed: 24109212
J Gen Virol. 2010 Feb;91(Pt 2):313-28
pubmed: 19955561
Proc Natl Acad Sci U S A. 1987 Nov;84(22):8140-4
pubmed: 2446318
J Virol. 2014 Dec;88(23):13879-91
pubmed: 25187553
J Gen Virol. 2018 Jan;99(1):3-16
pubmed: 29244017
Curr Opin Virol. 2016 Feb;16:114-119
pubmed: 26947779
Nature. 2017 Jun 29;546(7660):646-650
pubmed: 28636590
Cell Rep. 2013 Mar 28;3(3):769-78
pubmed: 23434510
Proc Natl Acad Sci U S A. 1976 Jun;73(6):2142-6
pubmed: 1064882
Nat Commun. 2016 Sep 21;7:12861
pubmed: 27650413
Front Immunol. 2017 Sep 11;8:1098
pubmed: 28959255
Zoonoses Public Health. 2015 May;62(3):187-9
pubmed: 24837569
Nat Microbiol. 2019 Dec;4(12):2298-2309
pubmed: 31527796
Trends Microbiol. 2018 Oct;26(10):841-853
pubmed: 29681430
Nature. 2014 Apr 10;508(7495):254-7
pubmed: 24531761
Nature. 2014 Dec 18;516(7531):355-60
pubmed: 25409142
J Virol. 2000 Jun;74(11):5206-12
pubmed: 10799596
J Virol. 2017 Jul 12;91(15):
pubmed: 28490593
Acta Crystallogr D Biol Crystallogr. 2006 Sep;62(Pt 9):947-52
pubmed: 16929094
J Gen Virol. 1994 Feb;75 ( Pt 2):381-8
pubmed: 8113759
Nature. 2019 Mar;567(7746):109-112
pubmed: 30787439
Proteins. 1989;6(4):341-56
pubmed: 2482974
Lab Anim (NY). 2004 Oct;33(9):50-3
pubmed: 15457202
Biochim Biophys Acta. 1991 Mar 8;1077(1):65-71
pubmed: 2009295
J Gen Virol. 2017 Apr;98(4):577-584
pubmed: 28100299
Clin Microbiol Rev. 2006 Jul;19(3):531-45
pubmed: 16847084
Annu Rev Virol. 2016 Sep 29;3(1):77-99
pubmed: 27578437
J Virol. 2018 Oct 24;93(2):
pubmed: 30355693
J Virol. 2019 Jan 4;93(2):
pubmed: 30381492
Cell. 2015 Jan 15;160(1-2):20-35
pubmed: 25533784
PLoS One. 2015 May 12;10(5):e0127035
pubmed: 25965069
J Virol. 2013 Nov;87(21):11316-22
pubmed: 23926345
PLoS Pathog. 2017 Mar 27;13(3):e1006288
pubmed: 28346537
Virology. 2016 Jan 15;488:43-50
pubmed: 26605499
PLoS Pathog. 2013;9(10):e1003657
pubmed: 24130481
PLoS One. 2015 Feb 23;10(2):e0117499
pubmed: 25706124
Emerg Infect Dis. 2019 Feb;25(2):333-337
pubmed: 30666923
Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12797-12802
pubmed: 27791106
J Gen Virol. 2016 Aug;97(8):1797-1806
pubmed: 27217257
Antimicrob Agents Chemother. 2014 Sep;58(9):5220-8
pubmed: 24957832
Emerg Microbes Infect. 2019;8(1):556-563
pubmed: 30945621
PLoS One. 2016 Mar 30;11(3):e0152134
pubmed: 27028521
Nat Commun. 2014 Jul 23;5:4448
pubmed: 25055345
J Virol. 2014 Nov;88(21):12572-85
pubmed: 25142579
Virology. 1998 May 10;244(2):315-21
pubmed: 9601502
Microbiol Rev. 1992 Mar;56(1):152-79
pubmed: 1579108
Dis Model Mech. 2011 Sep;4(5):575-9
pubmed: 21810904
Biochemistry. 1989 Oct 17;28(21):8388-96
pubmed: 2605190
J Virol. 2000 Jul;74(13):6015-20
pubmed: 10846083
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2002-7
pubmed: 12574509
PLoS Pathog. 2014 Oct 02;10(10):e1004420
pubmed: 25275541
J Clin Invest. 1998 Aug 15;102(4):792-803
pubmed: 9710448
Virology. 1997 Jun 9;232(2):345-50
pubmed: 9191848
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18903-8
pubmed: 23012478
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74
pubmed: 22371588
Virology. 1978 Feb;84(2):268-78
pubmed: 23604
Trends Microbiol. 2014 Apr;22(4):183-91
pubmed: 24582528

Auteurs

Kevin Ciminski (K)

Institute of Virology, Medical Center University of Freiburg, 79104 Freiburg, Germany.
Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.

Martin Schwemmle (M)

Institute of Virology, Medical Center University of Freiburg, 79104 Freiburg, Germany.
Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Bat-Borne Influenza A Viruses: An Awakening.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Chiroptera › Bat-Borne Influenza A Viruses: An Awakening.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Bat-Borne Influenza A Viruses: An Awakening.
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN de polarité négative › Orthomyxoviridae › Influenzavirus A › Virus de la grippe A › Bat-Borne Influenza A Viruses: An Awakening.
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Tropisme viral › Bat-Borne Influenza A Viruses: An Awakening.
questionsmedicales.fr › Maladies de l'animal › Zoonoses › Zoonoses virales › Bat-Borne Influenza A Viruses: An Awakening.
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Réplication virale › Bat-Borne Influenza A Viruses: An Awakening.